Murphy, Caitlin E. http://orcid.org/0000-0003-0216-6912
Walker, Adam K. http://orcid.org/0000-0003-3772-5745
O’Donnell, Maryanne http://orcid.org/0000-0002-9400-3688
Galletly, Cherrie
Lloyd, Andrew R. http://orcid.org/0000-0001-6277-8887
Liu, Dennis
Weickert, Cynthia Shannon
Weickert, Thomas W. http://orcid.org/0000-0002-6408-718X
Article History
Received: 19 July 2021
Revised: 23 November 2021
Accepted: 30 November 2021
First Online: 13 January 2022
Competing interests
: The authors declare no conflicts of interest pertaining to this article. ARL has received investigator-initiated research grant support but no personal remuneration from Gilead Sciences, AbbVie, and Sequiris. AKW is a recipient of a National Breast Cancer Foundation (Australia) fellowship (PF-15-014), and Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) grants, and is funded by Schizophrenia Research Institute and Neuroscience Research Australia (NeuRA).CSW is funded by the NSW Ministry of Health, Office of Health and Medical Research. CSW is a recipient of a National Health and Medical Research Council (Australia) Principal Research Fellowship (PRF) (#1117079). CSW is in collaboration with Astellas Pharma Inc., Japan.